Table 1 Proposed targets for TB R&D expenditure based on GDP and incidence
From: Determining quantitative targets for public funding of tuberculosis research and development
Country | GDP/Capita (USD million/ capita) | Present TB R&D (USD million) | Proposed target TB R&D (USD million) | ||
|---|---|---|---|---|---|
Global justice index | RoI factor | Total | |||
United States | 47,040 | 278 | 265 | 29.5 | 294 |
Switzerland | 45,236 | 2 | 6.3 | 0.9 | 7.2 |
United Kingdom | 36,030 | 33 | 30.2 | 6.5 | 36.8 |
Australia | 41,622 | 4 | 14.5 | 1.2 | 15.8 |
Japan | 33,873 | 1 | 54.3 | 51.5 | 106 |
South Africa | 10,676 | 3 | 1.5 | 90.0 | 91.5 |
China | 6,746 | 0.40 | 11.2 | 117.6 | 129 |
India | 1,143 | 6 | 1.2 | 57.4 | 58.6 |